GENE ONLINE|News &
Is Exosome the Next Rising Star?
The exosome diagnostics and therapeutics market was valued at US$ 46 million in 2019 and is expected to reach US$ 617 million by 2027 with a CAGR of 38%. The global growth mainly results from the rising prevalence of chronic diseases and incidence of cancer.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
GO Prime with only $1.49 now
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
